TickrTrends VTRS fair value analysis

Could an FDA Nod for MR-141 Give Viatris (VTRS) and Opus Genetics (IRD) a Presbyopia Payoff?

insidermonkey.com · 2026-10-08

Viatris Inc. (NASDAQ:VTRS) and Opus Genetics, Inc. (NASDAQ:IRD) are waiting on the same decision.

Read the full story at insidermonkey.com →

Is VTRS undervalued? See TickrTrends' fair value analysis →